866-997-4948(US-Canada Toll Free)

China Sorafenib Market Research Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 105 Pages

The global Sorafenib market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Sorafenib development status and future trend in China, focuses on top players in China, also splits Sorafenib by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
Pfizer
Allergan
Alnylam Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Levolta Pharmaceuticals
Mabtech

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Capsule
Tablet

On the basis of the end users/application, this report covers
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Table of Contents

China Sorafenib Market Research Report 2018
1 Sorafenib Overview
1.1 Product Overview and Scope of Sorafenib
1.2 Classification of Sorafenib by Product Category
1.2.1 China Sorafenib Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 China Sorafenib Sales (K Pcs) Market Share by Type in 2017
1.2.3 Capsule
1.2.4 Tablet
1.3 China Sorafenib Market by Application/End Users
1.3.1 China Sorafenib Sales (K Pcs) and Market Share Comparison by Applications (2013-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 China Sorafenib Market by Region
1.4.1 China Sorafenib Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Sorafenib Status and Prospect (2013-2025)
1.4.3 East China Sorafenib Status and Prospect (2013-2025)
1.4.4 Southwest China Sorafenib Status and Prospect (2013-2025)
1.4.5 Northeast China Sorafenib Status and Prospect (2013-2025)
1.4.6 North China Sorafenib Status and Prospect (2013-2025)
1.4.7 Central China Sorafenib Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Sorafenib (2013-2025)
1.5.1 China Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.5.2 China Sorafenib Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 China Sorafenib Market Competition by Players/Manufacturers
2.1 China Sorafenib Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Sorafenib Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Sorafenib Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 China Sorafenib Market Competitive Situation and Trends
2.4.1 China Sorafenib Market Concentration Rate
2.4.2 China Sorafenib Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Sorafenib Manufacturing Base Distribution, Sales Area, Product Types

3 China Sorafenib Sales and Revenue by Region (2013-2018)
3.1 China Sorafenib Sales (K Pcs) and Market Share by Region (2013-2018)
3.2 China Sorafenib Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Sorafenib Price (USD/Pcs) by Regions (2013-2018)

4 China Sorafenib Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Sorafenib Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
4.2 China Sorafenib Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Sorafenib Price (USD/Pcs) by Type (2013-2018)
4.4 China Sorafenib Sales Growth Rate (%) by Type (2013-2018)

5 China Sorafenib Sales by Application (2013-2018)
5.1 China Sorafenib Sales (K Pcs) and Market Share by Application (2013-2018)
5.2 China Sorafenib Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 China Sorafenib Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Sorafenib Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 Allergan
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Sorafenib Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Alnylam Pharmaceuticals
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Sorafenib Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Alnylam Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 Acceleron Pharma
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Sorafenib Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Acceleron Pharma Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 Biocon
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Sorafenib Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biocon Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Bionomics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Sorafenib Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bionomics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 CASI Pharmaceuticals
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Sorafenib Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 CASI Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Celgene Corporation
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Sorafenib Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celgene Corporation Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 Enzon Pharmaceuticals
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Sorafenib Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Enzon Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
6.10 Five Prime Therapeutics
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Sorafenib Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Five Prime Therapeutics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.10.4 Main Business/Business Overview
6.11 Fujifilm Kyowa Kirin Biologics
6.12 Genentech
6.13 Genexine
6.14 Hetero Drugs
6.15 ImClone Systems
6.16 Intas Pharmaceuticals
6.17 Levolta Pharmaceuticals
6.18 Mabtech

7 Sorafenib Manufacturing Cost Analysis
7.1 Sorafenib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sorafenib

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Sorafenib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 China Sorafenib Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Sorafenib Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
11.2 China Sorafenib Sales (K Pcs) Forecast by Type (2018-2025)
11.3 China Sorafenib Sales (K Pcs) Forecast by Application (2018-2025)
11.4 China Sorafenib Sales (K Pcs) Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Table

List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Sorafenib Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Sorafenib Sales (K Pcs) by Application (2013-2025)
Figure Product Picture of Sorafenib
Table China Sorafenib Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Sorafenib Sales Volume Market Share by Types in 2017
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure China Sorafenib Sales (K Pcs) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Sorafenib by Application in 2017
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure South China Sorafenib Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Sorafenib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Sorafenib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Sorafenib Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Sorafenib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Sorafenib Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure China Sorafenib Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Sorafenib Sales of Key Players/Manufacturers (2013-2018)
Table China Sorafenib Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Sorafenib Sales Share (%) by Players/Manufacturers
Figure 2017 China Sorafenib Sales Share (%) by Players/Manufacturers
Table China Sorafenib Revenue by Players/Manufacturers (2013-2018)
Table China Sorafenib Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Sorafenib Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Sorafenib Revenue Market Share (%) by Players/Manufacturers
Table China Market Sorafenib Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Sorafenib Average Price of Key Players/Manufacturers in 2017
Figure China Sorafenib Market Share of Top 3 Players/Manufacturers
Figure China Sorafenib Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Sorafenib Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Sorafenib Product Category
Table China Sorafenib Sales (K Pcs) by Regions (2013-2018)
Table China Sorafenib Sales Share (%) by Regions (2013-2018)
Figure China Sorafenib Sales Share (%) by Regions (2013-2018)
Figure China Sorafenib Sales Market Share (%) by Regions in 2017
Table China Sorafenib Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Sorafenib Revenue Market Share (%) by Regions (2013-2018)
Figure China Sorafenib Revenue Market Share (%) by Regions (2013-2018)
Figure China Sorafenib Revenue Market Share (%) by Regions in 2017
Table China Sorafenib Price (USD/Pcs) by Regions (2013-2018)
Table China Sorafenib Sales (K Pcs) by Type (2013-2018)
Table China Sorafenib Sales Share (%) by Type (2013-2018)
Figure China Sorafenib Sales Share (%) by Type (2013-2018)
Figure China Sorafenib Sales Market Share (%) by Type in 2017
Table China Sorafenib Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Sorafenib Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Sorafenib by Type (2013-2018)
Figure Revenue Market Share of Sorafenib by Type in 2017
Table China Sorafenib Price (USD/Pcs) by Types (2013-2018)
Figure China Sorafenib Sales Growth Rate (%) by Type (2013-2018)
Table China Sorafenib Sales (K Pcs) by Applications (2013-2018)
Table China Sorafenib Sales Market Share (%) by Applications (2013-2018)
Figure China Sorafenib Sales Market Share (%) by Application (2013-2018)
Figure China Sorafenib Sales Market Share (%) by Application in 2017
Table China Sorafenib Sales Growth Rate (%) by Application (2013-2018)
Figure China Sorafenib Sales Growth Rate (%) by Application (2013-2018)
Table Pfizer Sorafenib Basic Information List
Table Pfizer Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Pfizer Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Pfizer Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Allergan Sorafenib Basic Information List
Table Allergan Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Allergan Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Allergan Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Allergan Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Alnylam Pharmaceuticals Sorafenib Basic Information List
Table Alnylam Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Alnylam Pharmaceuticals Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Alnylam Pharmaceuticals Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Alnylam Pharmaceuticals Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Acceleron Pharma Sorafenib Basic Information List
Table Acceleron Pharma Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Acceleron Pharma Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Acceleron Pharma Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Acceleron Pharma Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Biocon Sorafenib Basic Information List
Table Biocon Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Biocon Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Biocon Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Biocon Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Bionomics Sorafenib Basic Information List
Table Bionomics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bionomics Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Bionomics Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Bionomics Sorafenib Revenue Market Share (%) in China (2013-2018)
Table CASI Pharmaceuticals Sorafenib Basic Information List
Table CASI Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure CASI Pharmaceuticals Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure CASI Pharmaceuticals Sorafenib Sales Market Share (%) in China (2013-2018)
Figure CASI Pharmaceuticals Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Celgene Corporation Sorafenib Basic Information List
Table Celgene Corporation Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Celgene Corporation Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Celgene Corporation Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Celgene Corporation Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Enzon Pharmaceuticals Sorafenib Basic Information List
Table Enzon Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Enzon Pharmaceuticals Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Enzon Pharmaceuticals Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Enzon Pharmaceuticals Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Five Prime Therapeutics Sorafenib Basic Information List
Table Five Prime Therapeutics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Five Prime Therapeutics Sorafenib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Five Prime Therapeutics Sorafenib Sales Market Share (%) in China (2013-2018)
Figure Five Prime Therapeutics Sorafenib Revenue Market Share (%) in China (2013-2018)
Table Fujifilm Kyowa Kirin Biologics Sorafenib Basic Information List
Table Genentech Sorafenib Basic Information List
Table Genexine Sorafenib Basic Information List
Table Hetero Drugs Sorafenib Basic Information List
Table ImClone Systems Sorafenib Basic Information List
Table Intas Pharmaceuticals Sorafenib Basic Information List
Table Levolta Pharmaceuticals Sorafenib Basic Information List
Table Mabtech Sorafenib Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Figure Manufacturing Process Analysis of Sorafenib
Figure Sorafenib Industrial Chain Analysis
Table Raw Materials Sources of Sorafenib Major Players/Manufacturers in 2017
Table Major Buyers of Sorafenib
Table Distributors/Traders List
Figure China Sorafenib Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure China Sorafenib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Sorafenib Price (USD/Pcs) Trend Forecast (2018-2025)
Table China Sorafenib Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Sorafenib Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Sorafenib Sales Volume Market Share Forecast by Type in 2025
Table China Sorafenib Sales (K Pcs) Forecast by Application (2018-2025)
Figure China Sorafenib Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Sorafenib Sales Volume Market Share Forecast by Application in 2025
Table China Sorafenib Sales (K Pcs) Forecast by Regions (2018-2025)
Table China Sorafenib Sales Volume Share Forecast by Regions (2018-2025)
Figure China Sorafenib Sales Volume Share Forecast by Regions (2018-2025)
Figure China Sorafenib Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *